期刊
YEAR IN DIABETES AND OBESITY
卷 1281, 期 -, 页码 92-105出版社
BLACKWELL SCIENCE PUBL
DOI: 10.1111/nyas.12031
关键词
beta cell; islets; diabetes; neogenesis; insulin secretion
资金
- National Institutes of Health [R01 DK 66056, DK 93909, P30 DK36836]
- Juvenile Diabetes Research Foundation
- American Diabetes Association
- Diabetes Research and Wellness Foundation
In type 1 diabetes (T1D) beta cell mass is markedly reduced by autoimmunity. Type 2 diabetes (T2D) results from inadequate beta cell mass and function that can no longer compensate for insulin resistance. The reduction of beta cell mass in T2D may result from increased cell death and/or inadequate birth through replication and neogenesis. Reduction in mass allows glucose levels to rise, which places beta cells in an unfamiliar hyperglycemic environment, leading to marked changes in their phenotype and a dramatic loss of glucose-stimulated insulin secretion (GSIS), which worsens as glucose levels climb. Toxic effects of glucose on beta cells (glucotoxicity) appear to be the culprit. This dysfunctional insulin secretion can be reversed when glucose levels are lowered by treatment, a finding with therapeutic significance. Restoration of beta cell mass in both types of diabetes could be accomplished by either beta cell regeneration or transplantation. Learning more about the relationships between beta cell mass, turnover, and function and finding ways to restore beta cell mass are among the most urgent priorities for diabetes research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据